Study Group Alegent Creighton Health Research Center (Ref number:163)
Description An open-label, multicenter phase II study to examine the efficacy and safety of everolimus as second-line therapy in the treatment of patients with metastatic renal cell carcinoma (RECORD-4)
Study Number Record 4
Disease Site Renal Cell Cancer
Phone Number 402-717-4728
Contact Name JoAnn Wilde